F M Panfili, A Convertino, G Grugni, L Mazzitelli, S Bocchini, A Crinò, G Campana, M Cappa, M Delvecchio, M F Faienza, M R Licenziati, M Mariani, S Osimani, R Pajno, G Patti, I Rutigliano, M Sacco, E Scarano, D Fintini
PURPOSE: 25OHD levels in patients with Prader-Willi Syndrome (PWS), the most frequent cause of genetic obesity with a peculiar fat mass distribution, are still debated. Insulin resistance (IR), Body Mass Index-SDS (BMI-SDS), Growth Hormone Therapy (GHT), and puberty onset seem to interact with 25OHD levels. The objectives of the study are: (1) To analyze 25OHD levels in pediatric PWS patients in comparison with a control group (CNT) (2) To evaluate a possible correlation between BMI-SDS, HOMA-IR, puberty, GHT, and 25OHD levels...
July 2023: Journal of Endocrinological Investigation